Newsroom

Categories: Research, Corporate, Finance & Investor, biopharma

GenNext and Agilent unveil groundbreaking technology integration to accelerate high-value decision making in biopharmaceutical research

September 11, 2024

Categories: General Laboratory, biopharma

Synexa Life Sciences expands biomarker discovery capabilities with the addition of Olink® target platform

March 4, 2024

Categories: Biotechnology, Drug Discovery & Development, biopharma

GenNext® Technologies announces partnership with Emery Pharma on full-solution biopharmaceutical protein footprinting services

May 17, 2023

Categories: Analytical Chemistry, biopharma

New application-specific LC system to precisely deliver high-purity products or isolation of contaminants

October 10, 2022

Categories: Pharma, Corporate, Finance & Investor, biopharma

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development.

May 19, 2022

Categories: Drug Discovery & Development, Corporate, Finance & Investor, biopharma

Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET inhibitors for non-small cell lung cancer

March 7, 2022

Categories: Corporate, Finance & Investor, biopharma

Thermo Fisher Scientific continues collaboration to support biopharmaceutical discovery and development

March 1, 2022

Categories: Healthcare, COVID-19, biopharma

Noorik Biopharmaceuticals announces the signing of a development contract with the Federal Government of Switzerland to develop ambrisentan as a treatment for severe COVID-19

December 15, 2021

Categories: Omics & Genetics, Computing & Technology, biopharma

Updated software solutions enable new insights and productivity

November 1, 2021